The pathophysiology of murine retrovirus-induced leukemias.
Murine leukemia viruses (MuLVs) are retroviruses which induce a broad spectrum of hematopoietic malignancies. In contrast to the acutely transforming retroviruses, MuLVs do not contain transduced cellular genes, or oncogenes. Nonetheless, MuLVs can cause leukemias quickly (4 to 6 weeks) and efficiently (up to 100% incidence) in susceptible strains of mice. The molecular basis of MuLV-induced leukemia is not clear. However, the contribution of individual viral genes to leukemogenesis can be assayed by creating novel viruses in vitro using recombinant DNA techniques. These genetically engineered viruses are tested in vivo for their ability to cause leukemia. Leukemogenic MuLVs possess genetic sequences which are not found in nonleukemogenic viruses. These sequences control the histologic type, incidence, and latency of disease induced by individual MuL Vs.
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D003001:Cloning, Molecular; D004261:DNA Replication; D004279:DNA, Viral / Q000235:genetics / Q000378:metabolism*; D005622:Friend murine leukemia virus; D005814:Genes, Viral; D006664:History; D004915:Leukemia, Erythroblastic, Acute; D007942:Leukemia, Experimental / Q000503:physiopathology*; D051379:Mice; D011995:Recombination, Genetic; D012190:Retroviridae / Q000145:classification / Q000235:genetics*; D014412:Tumor Virus Infections / Q000503:physiopathology*; D014779:Virus Replication
D004279:DNA, Viral